Last reviewed · How we verify
Normal-dose Wenxin Granules
Normal-dose Wenxin Granules is a Small molecule drug developed by China Academy of Chinese Medical Sciences. It is currently FDA-approved.
At a glance
| Generic name | Normal-dose Wenxin Granules |
|---|---|
| Sponsor | China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Normal-dose Wenxin Granules CI brief — competitive landscape report
- Normal-dose Wenxin Granules updates RSS · CI watch RSS
- China Academy of Chinese Medical Sciences portfolio CI
Frequently asked questions about Normal-dose Wenxin Granules
What is Normal-dose Wenxin Granules?
Normal-dose Wenxin Granules is a Small molecule drug developed by China Academy of Chinese Medical Sciences.
Who makes Normal-dose Wenxin Granules?
Normal-dose Wenxin Granules is developed and marketed by China Academy of Chinese Medical Sciences (see full China Academy of Chinese Medical Sciences pipeline at /company/china-academy-of-chinese-medical-sciences).
What development phase is Normal-dose Wenxin Granules in?
Normal-dose Wenxin Granules is FDA-approved (marketed).